Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC)
CUSIP: 761330109
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 104,661,494
- Total 13F shares
- 28,779,485
- Share change
- +1,472,695
- Total reported value
- $391,398,386
- Put/Call ratio
- 104%
- Price per share
- $13.60
- Number of holders
- 79
- Value change
- +$16,844,693
- Number of buys
- 42
- Number of sells
- 31
Quarterly Holders Quick Answers
What is CUSIP 761330109?
CUSIP 761330109 identifies RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 761330109:
Top shareholders of RVNC - Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. |
13F
|
Company |
4.4%
|
4,592,047
|
$80,177,000 | — | 31 Mar 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
3.2%
|
3,329,070
|
$58,126,000 | — | 31 Mar 2016 | |
| NQ HCIF GP, Ltd. |
13F
|
Company |
3%
|
3,096,650
|
$54,068,000 | — | 31 Mar 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.9%
|
3,028,574
|
$52,879,000 | — | 31 Mar 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.9%
|
1,966,165
|
$34,329,000 | — | 31 Mar 2016 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.6%
|
1,651,426
|
$28,834,000 | — | 31 Mar 2016 | |
| Polar Capital LLP |
13F
|
Company |
1.1%
|
1,183,631
|
$20,665,000 | — | 31 Mar 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
1.1%
|
1,150,499
|
$20,088,000 | — | 31 Mar 2016 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.1%
|
1,134,796
|
$19,814,000 | — | 31 Mar 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.67%
|
704,340
|
$12,297,000 | — | 31 Mar 2016 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.58%
|
610,300
|
$10,656,000 | — | 31 Mar 2016 | |
| STATE STREET CORP |
13F
|
Company |
0.5%
|
527,316
|
$9,206,000 | — | 31 Mar 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
0.47%
|
492,407
|
$8,597,000 | — | 31 Mar 2016 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.36%
|
375,000
|
$6,548,000 | — | 31 Mar 2016 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.34%
|
353,850
|
$6,178,000 | — | 31 Mar 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.29%
|
300,056
|
$5,239,000 | — | 31 Mar 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.21%
|
214,855
|
$3,751,000 | — | 31 Mar 2016 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.16%
|
170,000
|
$2,968,000 | — | 31 Mar 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
140,040
|
$2,445,000 | — | 31 Mar 2016 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
117,168
|
$2,046,000 | — | 31 Mar 2016 | |
| JHL Capital Group LLC |
13F
|
Company |
0.11%
|
110,000
|
$1,921,000 | — | 31 Mar 2016 | |
| Vivo Capital, LLC |
13F
|
Company |
0.07%
|
77,373
|
$1,886,000 | — | 31 Mar 2016 | |
| Baird Financial Group, Inc. |
13F
|
Company |
0.1%
|
106,265
|
$1,855,000 | — | 31 Mar 2016 | |
| SUFFOLK CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.09%
|
96,471
|
$1,684,000 | — | 31 Mar 2016 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.09%
|
94,700
|
$1,653,000 | — | 31 Mar 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
93,115
|
$1,626,000 | — | 31 Mar 2016 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
84,288
|
$1,472,000 | — | 31 Mar 2016 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.08%
|
82,890
|
$1,447,000 | — | 31 Mar 2016 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.08%
|
81,701
|
$1,426,000 | — | 31 Mar 2016 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.08%
|
81,272
|
$1,419,000 | — | 31 Mar 2016 | |
| UNITED BANK |
13F
|
Company |
0.07%
|
77,177
|
$1,348,000 | — | 31 Mar 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
75,196
|
$1,312,000 | — | 31 Mar 2016 | |
| Invesco Ltd. |
13F
|
Company |
0.07%
|
69,594
|
$1,215,000 | — | 31 Mar 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0.06%
|
65,170
|
$1,138,000 | — | 31 Mar 2016 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
64,943
|
$1,134,000 | — | 31 Mar 2016 | |
| COLUMBUS CIRCLE INVESTORS |
13F
|
Company |
0.06%
|
63,398
|
$1,107,000 | — | 31 Mar 2016 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.05%
|
55,715
|
$973,000 | — | 31 Mar 2016 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.05%
|
54,621
|
$954,000 | — | 31 Mar 2016 | |
| Trexquant Investment LP |
13F
|
Company |
0.05%
|
48,002
|
$838,000 | — | 31 Mar 2016 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.04%
|
45,000
|
$786,000 | — | 31 Mar 2016 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
39,781
|
$695,000 | — | 31 Mar 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.04%
|
39,283
|
$685,000 | — | 31 Mar 2016 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
38,794
|
$677,000 | — | 31 Mar 2016 | |
| NOTTINGHAM ADVISORS, INC. |
13F
|
Company |
0.02%
|
18,328
|
$626,000 | — | 31 Mar 2016 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.03%
|
31,559
|
$551,000 | — | 31 Mar 2016 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.03%
|
29,750
|
$519,000 | — | 31 Mar 2016 | |
| Swiss National Bank |
13F
|
Company |
0.03%
|
30,750
|
$518,000 | — | 31 Mar 2016 | |
| State of New Jersey Common Pension Fund D |
13F
|
Company |
0.02%
|
26,000
|
$454,000 | — | 31 Mar 2016 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
25,300
|
$442,000 | — | 31 Mar 2016 | |
| ProShare Advisors LLC |
13F
|
Company |
0.02%
|
23,018
|
$402,000 | — | 31 Mar 2016 |
Institutional Holders of Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) as of Q2 2016
As of 30 Jun 2016,
Revance Therapeutics, Inc. - Common Stock, par value $0.001 per share (RVNC) was held by
79 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,779,485 shares.
The largest 10 holders included
Essex Woodlands Health Ventures, Inc., JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, NQ HCIF GP, Ltd., WELLINGTON MANAGEMENT GROUP LLP, Bank of New York Mellon Corp, Arrowpoint Asset Management, LLC, BlackRock Fund Advisors, Polar Capital LLP, and VANGUARD GROUP INC.
This page lists
79
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
83
Q2 2016 holders
79
Holder diff
-4
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.